Friday, October 3, 2014

* Amazon.com (AMZN) - Five Chart that are Interesting if Not Breathtaking


Share on StockTwits





This visualization is provided by: Capital Market Laboratories

Join the limited queue for CML Light

Conclusion
AMZN has enormous (enormous) revenue and that revenue continues to grow.... well, enormously. AMZN has growing gross margin % in the last couple of years and has a growing book value. There's really only one thing AMZN is missing... Earnings.

Let's look at five visualizations that are interesting at the every least and breathtaking at the most.



Total Revenue (TTM)
That's a beautiful chart and it doesn't look like it ever wants to stop.  In the trailing-twelve-months AMZN has generated over $80B in revenue.  That's crazy...



Book Value per Share
AMZN's book value has increased rapidly with revenue, although I do note, as of right now, the stock is ~ 15x book.



Gross Margin %
Believe it or not... AMZN is growing its gross margin %.  That's almost unbelievable for a firm with revenue so large and growing so rapidly.  But, alas, there it is... gross margin % has risen from ~23% to now ~27%.  On $80B in revenue, that's ~$320 in gross profit increase.



Net Income (TTM)
Well... at one point (which isn't often spoken of) the firm produced a net income of over $1B in a year.  Actually, the firm did it for a while... That time is not now.



Peering
So here's the "problem" in a nutshell (or in a chart if you prefer). On the x-axis we have revenue.  We can see that in this peer group AMZN has the fifth largest total revenue falling into the same category as firms like MSFT, IBM, HPQ and AAPL.  It has larger revenue than GOOGL and ORCL (totally different businesses, of course.)

On the y-axis we have net income (aka earnings).  Check this out:



AMZN has HUGE revenue, but it's right near the bottom for earnings.  Contrast that with BABA, which has "only" $9B in revenue but $5B in net income (or so the financial filings read).

Now AMZN has introduced a mobile phone... so I suppose revenue will rise and rise and rise some more.  Will the firm earn any money... I have no idea...


This is trade analysis, not a recommendation.






Legal Stuff:
Options involve risk. Prior to buying or selling an option, an investor must receive a copy of Characteristics and Risks of Standardized Options. Investors need a broker to trade options, and must meet suitability requirements.

The information contained on this site is provided for general informational purposes, as a convenience to the readers. The materials are not a substitute for obtaining professional advice from a qualified person, firm or corporation. Consult the appropriate professional advisor for more complete and current information. I am not engaged in rendering any legal or professional services by placing these general informational materials on this website.

I specifically disclaim any liability, whether based in contract, tort, strict liability or otherwise, for any direct, indirect, incidental, consequential, or special damages arising out of or in any way connected with access to or use of the site, even if I have been advised of the possibility of such damages, including liability in connection with mistakes or omissions in, or delays in transmission of, information to or from the user, interruptions in telecommunications connections to the site or viruses.

I make no representations or warranties about the accuracy or completeness of the information contained on this website. Any links provided to other server sites are offered as a matter of convenience and in no way are meant to imply that I endorse, sponsor, promote or am affiliated with the owners of or participants in those sites, or endorse any information contained on those sites, unless expressly stated.

10-3-14: End of Day Report

Share on StockTwits








Top Headlines
* Dow jumps following surge in hiring last month

* Ebola epidemic: Which sectors to watch

* Where the big money is putting their money now

Top Laboratory Story
* Micro-Cap Biotechs: The Next Billion Dollar Drug Is Coming From...?

Open Interest
* Daily Open Interest Report

Covered Call
* Daily Covered Call Report

Biotech Index
* Daily Biotech Small & Micro Cap Update

Market Overview

Largest Stock Gainers



Largest Stock Losers



New 52 Wk Highs in S&P 500



New 52 Wk Lows in S&P 500



Unusual Option Volume



This is trade analysis, not a recommendation.






Legal Stuff:
Options involve risk. Prior to buying or selling an option, an investor must receive a copy of Characteristics and Risks of Standardized Options. Investors need a broker to trade options, and must meet suitability requirements.

The information contained on this site is provided for general informational purposes, as a convenience to the readers. The materials are not a substitute for obtaining professional advice from a qualified person, firm or corporation. Consult the appropriate professional advisor for more complete and current information. I am not engaged in rendering any legal or professional services by placing these general informational materials on this website.

I specifically disclaim any liability, whether based in contract, tort, strict liability or otherwise, for any direct, indirect, incidental, consequential, or special damages arising out of or in any way connected with access to or use of the site, even if I have been advised of the possibility of such damages, including liability in connection with mistakes or omissions in, or delays in transmission of, information to or from the user, interruptions in telecommunications connections to the site or viruses.

I make no representations or warranties about the accuracy or completeness of the information contained on this website. Any links provided to other server sites are offered as a matter of convenience and in no way are meant to imply that I endorse, sponsor, promote or am affiliated with the owners of or participants in those sites, or endorse any information contained on those sites, unless expressly stated.

10-3-14: Daily Biotech Small & Micro Cap Update

Share on StockTwits

The Ophir Gottlieb Small Cap Biotech Index
Is this the biotech revolution or the biotech bust?



Notable Stock Movers
AOBI+148.76%
PARD+25%
RMTI+15.8%
TELKD-8.96%
GOVX-11.39%
XTLB-14.2%



Unusually Heavy Option Volume
PTLA:1011% of daily average
NNVC:1834% of daily average
KERX:765% of daily average

231 small / micro cap biotech and pharma companies (equal weighted):
  • Public Biotech and Pharma Companies
  • Trade on North American Exchanges
  • Market Cap Range: [$0, $2 Billion]
  • Price, Employees, Revenue Range: Any

More on index construction and performance: The Ophir Gottlieb Small Cap Biotech Index

Today's Biotech Index Stock Movers



Today's Biotech Index Unusual Option Volume



Full Index Constituents and Moves




This is trade analysis, not a recommendation.






Legal Stuff:
Options involve risk. Prior to buying or selling an option, an investor must receive a copy of Characteristics and Risks of Standardized Options. Investors need a broker to trade options, and must meet suitability requirements.

The information contained on this site is provided for general informational purposes, as a convenience to the readers. The materials are not a substitute for obtaining professional advice from a qualified person, firm or corporation. Consult the appropriate professional advisor for more complete and current information. I am not engaged in rendering any legal or professional services by placing these general informational materials on this website.

I specifically disclaim any liability, whether based in contract, tort, strict liability or otherwise, for any direct, indirect, incidental, consequential, or special damages arising out of or in any way connected with access to or use of the site, even if I have been advised of the possibility of such damages, including liability in connection with mistakes or omissions in, or delays in transmission of, information to or from the user, interruptions in telecommunications connections to the site or viruses.

I make no representations or warranties about the accuracy or completeness of the information contained on this website. Any links provided to other server sites are offered as a matter of convenience and in no way are meant to imply that I endorse, sponsor, promote or am affiliated with the owners of or participants in those sites, or endorse any information contained on those sites, unless expressly stated.

10-3-14: Daily Open Interest Report

Share on StockTwits



Daily Option Interest Report

Notable One-day Option Position Increases
MPO+3128%
TCS+2605%
GEVO+2448%
Full List Below



Notable Large Option Position Increases Relative to 3-month Average
BAGL+966%
VIMC+554%
AKBA+475%
Full List Below

Largest One-day Open Interest Increases



Largest Current Open Interest Relative to 90-day Average




This is trade analysis, not a recommendation.






Legal Stuff:
Options involve risk. Prior to buying or selling an option, an investor must receive a copy of Characteristics and Risks of Standardized Options. Investors need a broker to trade options, and must meet suitability requirements.

The information contained on this site is provided for general informational purposes, as a convenience to the readers. The materials are not a substitute for obtaining professional advice from a qualified person, firm or corporation. Consult the appropriate professional advisor for more complete and current information. I am not engaged in rendering any legal or professional services by placing these general informational materials on this website.

I specifically disclaim any liability, whether based in contract, tort, strict liability or otherwise, for any direct, indirect, incidental, consequential, or special damages arising out of or in any way connected with access to or use of the site, even if I have been advised of the possibility of such damages, including liability in connection with mistakes or omissions in, or delays in transmission of, information to or from the user, interruptions in telecommunications connections to the site or viruses.

I make no representations or warranties about the accuracy or completeness of the information contained on this website. Any links provided to other server sites are offered as a matter of convenience and in no way are meant to imply that I endorse, sponsor, promote or am affiliated with the owners of or participants in those sites, or endorse any information contained on those sites, unless expressly stated.

10-3-14: Daily Covered Call Report

Share on StockTwits



Requirements
  • 1 million+ shares average daily volume
  • IV > 10%
  • IV < 60% 
  • Static Return (unassigned) > 5%

This information is available via optionsXpress ---> Idea Hub






This is trade analysis, not a recommendation.






Legal Stuff:
Options involve risk. Prior to buying or selling an option, an investor must receive a copy of Characteristics and Risks of Standardized Options. Investors need a broker to trade options, and must meet suitability requirements.

The information contained on this site is provided for general informational purposes, as a convenience to the readers. The materials are not a substitute for obtaining professional advice from a qualified person, firm or corporation. Consult the appropriate professional advisor for more complete and current information. I am not engaged in rendering any legal or professional services by placing these general informational materials on this website.

I specifically disclaim any liability, whether based in contract, tort, strict liability or otherwise, for any direct, indirect, incidental, consequential, or special damages arising out of or in any way connected with access to or use of the site, even if I have been advised of the possibility of such damages, including liability in connection with mistakes or omissions in, or delays in transmission of, information to or from the user, interruptions in telecommunications connections to the site or viruses.

I make no representations or warranties about the accuracy or completeness of the information contained on this website. Any links provided to other server sites are offered as a matter of convenience and in no way are meant to imply that I endorse, sponsor, promote or am affiliated with the owners of or participants in those sites, or endorse any information contained on those sites, unless expressly stated.

Thursday, October 2, 2014

* Micro-Cap Biotechs: The Next Billion Dollar Drug Is Coming From...?


Share on StockTwits



This visualization is provided by: Capital Market Laboratories (join the queue: free trial)



Micro Cap Bio-techs: Who's Investing in R&D?
Note that the firms above the blue line I've drawn in are pouring in at least $0.60 into research & development out of every $1 in operating expense,  All of the firms here are between [$100M, $500M] in market cap.  These are the babies, many of which will go away... and a few which may explode.


---> Full Size Image



This is trade analysis, not a recommendation.






Legal Stuff:
Options involve risk. Prior to buying or selling an option, an investor must receive a copy of Characteristics and Risks of Standardized Options. Investors need a broker to trade options, and must meet suitability requirements.

The information contained on this site is provided for general informational purposes, as a convenience to the readers. The materials are not a substitute for obtaining professional advice from a qualified person, firm or corporation. Consult the appropriate professional advisor for more complete and current information. I am not engaged in rendering any legal or professional services by placing these general informational materials on this website.

I specifically disclaim any liability, whether based in contract, tort, strict liability or otherwise, for any direct, indirect, incidental, consequential, or special damages arising out of or in any way connected with access to or use of the site, even if I have been advised of the possibility of such damages, including liability in connection with mistakes or omissions in, or delays in transmission of, information to or from the user, interruptions in telecommunications connections to the site or viruses.

I make no representations or warranties about the accuracy or completeness of the information contained on this website. Any links provided to other server sites are offered as a matter of convenience and in no way are meant to imply that I endorse, sponsor, promote or am affiliated with the owners of or participants in those sites, or endorse any information contained on those sites, unless expressly stated.